Power-Pak C.E. is pleased to present a complimentary CE WEBINAR |
|
Goal To provide oncology, managed care and specialty pharmacists with advanced knowledge of how to optimally manage adult patients with advanced non-small-cell lung cancer (NSCLC) receiving immune-oncology (I-O) therapy, such that they can identify and recommend appropriate patient-specific treatments that are cost-effective, develop optimal toxicity prevention and management, and to improve patient outcomes. | |
Educational Objectives Upon completion of this program, participants should be better able to: |
• |
Discuss the standard-of-care options for patients with advanced non-small-cell lung cancer (NSCLC), including immune-oncology (I-O) therapies |
• |
Examine the emerging data for I-O and I-O combination regimens in the treatment of advanced NSCLC |
• |
Identify appropriate prognostic and predictive biomarkers in the treatment of advanced NSCLC with I-O alone or in combination regimens |
• |
Demonstrate pharmacist-driven strategies to recognize and prevent or manage toxicities associated I-O or I-O combination therapies throughout the continuum of care |
|
|
Agenda |
|
1:00 – 1:05 PM | Introduction 1:05 – 2:20 PM | Presentation 2:20 – 2:30 PM | Question & Answer Session |
How to Earn Credit Participants must attend and participate in the entire live educational activity and complete the evaluation form directly after the event with a maximum of within 60 days of participating in the activity. | ||||||||||||
Required Computer Hardware/Software (to claim credit) Please ensure the computer system you plan to use meets the following minimum requirements: | ||||||||||||
|
||||||||||||
Accreditation Statements |
||||||||||||
|
||||||||||||
|